The Peptide Craze Ground Truths BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with FDA moves toward easing restrictions on certain peptides BioPharma Dive The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype The FDA just announced that they're taking steps to lift restrictions on 12 peptides including BPC 157 and TB 500 making them accessible through compounding pharmacies again. This is a HUGE step Bpc 157 bone healing: 2025's Crucial Warning.